209 related articles for article (PubMed ID: 17336841)
1. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
3. MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction.
Wilkinson JM; Davidson RK; Swingler TE; Jones ER; Corps AN; Johnston P; Riley GP; Chojnowski AJ; Clark IM
Biochim Biophys Acta; 2012 Jun; 1822(6):897-905. PubMed ID: 22342364
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease.
Johnston P; Larson D; Clark IM; Chojnowski AJ
J Hand Surg Am; 2008 Sep; 33(7):1160-7. PubMed ID: 18762113
[TBL] [Abstract][Full Text] [Related]
6. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
8. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.
Shih B; Wijeratne D; Armstrong DJ; Lindau T; Day P; Bayat A
J Hand Surg Am; 2009 Jan; 34(1):124-36. PubMed ID: 19121738
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of collagen synthesis and matrix metalloproteinase expression in myofibroblasts from Dupuytren nodule using adenovirus-mediated relaxin gene therapy.
Kang YM; Choi YR; Yun CO; Park JO; Suk KS; Kim HS; Park MS; Lee BH; Lee HM; Moon SH
J Orthop Res; 2014 Apr; 32(4):515-23. PubMed ID: 24293067
[TBL] [Abstract][Full Text] [Related]
10. Gelatinase A activity in Dupuytren's disease.
Augoff K; Ratajczak K; Gosk J; Tabola R; Rutowski R
J Hand Surg Am; 2006 Dec; 31(10):1635-9. PubMed ID: 17145384
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.
Davidson RK; Waters JG; Kevorkian L; Darrah C; Cooper A; Donell ST; Clark IM
Arthritis Res Ther; 2006; 8(4):R124. PubMed ID: 16859525
[TBL] [Abstract][Full Text] [Related]
12. The mechanical environment in Dupuytren's contracture determines cell contractility and associated MMP-mediated matrix remodeling.
Verhoekx JS; Beckett KS; Bisson MA; McGrouther DA; Grobbelaar AO; Mudera V
J Orthop Res; 2013 Feb; 31(2):328-34. PubMed ID: 22987740
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.
Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
J Hand Surg Am; 2008 Nov; 33(9):1608-16. PubMed ID: 18984345
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
15. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
16. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
18. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
19. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.
Forrester HB; Temple-Smith P; Ham S; de Kretser D; Southwick G; Sprung CN
PLoS One; 2013; 8(3):e59056. PubMed ID: 23554969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
